Showing results (321-330 of 341) with videos related to

Sort By:
Pageof 35
Science Translational Medicine|August 25, 2021
Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19Monique G P van der Wijst, Sara E Vazquez, George C Hartoularos, et al.
Thorax|June 2, 2023
Pulmonary emphysema subtypes defined by unsupervised machine learning on CT scansElsa D Angelini, Jie Yang, Pallavi P Balte, et al.
Circulation. Heart Failure|November 5, 2025
SPIROMICS HF: Rationale, Design, and Reproducibility of MeasuresR Graham Barr, Joao A C Lima, Martin R Prince, et al.
Plos Genetics|August 18, 2016
Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPDWei Sun, Katerina Kechris, Sean Jacobson, et al.
The Journal of Allergy and Clinical Immunology. Global|July 25, 2025
Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohortNaresh Doni Jayavelu, Jingjing Qi, Carly E Milliren, et al.
Nature|December 10, 2013
Muc5b is required for airway defenceMichelle G Roy, Alessandra Livraghi-Butrico, Ashley A Fletcher, et al.
JAMA Network Open|June 17, 2024
Epidemiologic Features of Recovery From SARS-CoV-2 InfectionElizabeth C Oelsner, Yifei Sun, Pallavi P Balte, et al.
Cell|October 5, 2019
An Allosteric Anti-tryptase Antibody for the Treatment of Mast Cell-Mediated Severe AsthmaHenry R Maun, Janet K Jackman, David F Choy, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Omic Risk Scores are Associated with COPD-related Traits Across Three CohortsIain R Konigsberg, Luciana B Vargas, Katherine A Pratte, et al.
Annals of the American Thoracic Society|June 23, 2023
Systemic Markers of Lung Function and Forced Expiratory Volume in 1 Second Decline across Diverse CohortsDebby Ngo, Katherine A Pratte, Claudia Flexeder, et al.
Pageof 35